Trials / Completed
CompletedNCT00320203
Anecortave Acetate in Patients With Open-angle Glaucoma
A Study of the Safety and IOP-Lowering Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 86 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety, efficacy, and duration of effect of a single administration of Anecortave Acetate Depot for treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anecortave Acetate Sterile Suspension, 6 mg/mL | Single injection, anterior juxtascleral depot (AJD) |
| DRUG | Anecortave Acetate Sterile Suspension, 30 mg/mL | Single injection, anterior juxtascleral depot (AJD) |
| DRUG | Anecortave Acetate Sterile Suspension, 60 mg/mL | Single injection, anterior juxtascleral depot (AJD) |
| OTHER | Anecortave Acetate Vehicle | Single injection, anterior juxtascleral depot (AJD) |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2008-01-01
- Completion
- 2008-01-01
- First posted
- 2006-05-03
- Last updated
- 2012-11-28
Source: ClinicalTrials.gov record NCT00320203. Inclusion in this directory is not an endorsement.